skip navigation
Vol. LVII, No. 22
November 4, 2005

previous story

next story
Straus Lecture Travels from Bench to Bedside and Back
Dr. Stephen Straus  
We have all heard the terms "from bench to bedside" or "translational research" — taking the discoveries of the laboratory to the patient. But translational research is more than that; it is also taking clinical observations back to the laboratory to produce research results to use at the bedside. An upcoming NIH Director's Lecture will focus on the cycle of translational research as viewed through studies of the herpes simplex and varicella zoster viruses led by Dr. Stephen Straus, senior investigator, Laboratory of Clinical Infectious Diseases, NIAID, and director, National Center for Complementary and Alternative Medicine.

On Tuesday, Nov. 15 at 3 p.m. in Masur Auditorium, Bldg. 10, Straus will share insights from more than 20 years of translational research of these common human herpesvirus diseases. He will take the audience from molecular biology, to pathogenesis, to treatment and prevention of these diseases and their complications and show how work progressed because of lessons he and his colleagues learned from their patients, in addition to laboratory studies. This research ultimately led to the development and testing of novel drug and vaccine strategies for genital herpes and shingles.